Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma

NCT01405235 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

312

Enrollment

OTHER

Sponsor class

Conditions

Recurrent, Persistent or Metastasized Cervical Cancer

Interventions

DRUG: Paclitaxel
DRUG: Cisplatin/Paclitaxel

Sponsor

Institut fuer Frauengesundheit

Collaborators

[object Object]
[object Object]